Company intelligence / Profile preview

Medicyte

Heidelberg, Baden-Württemberg, Germany

Ownership: Private
Development stage: Other

Overview

Medicyte specialized in the controlled generation and standardization of human primary cell products, particularly hepatocytes, for pharmaceutical and research applications. The company achieved commercial stage with products available through an online shop before liquidation.

Modalities: Cell therapy
Industry: Non-Drug Biotech

Partnerships

PRIMACYT (collaborative grant recipient for developing human liver cells)

Beyond the preview

Go deeper on Medicyte.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medicyte.

Explore the full profile